NO975681D0 - Benzisoxazol- og indazol-derivater som antipsykotiske midler - Google Patents

Benzisoxazol- og indazol-derivater som antipsykotiske midler

Info

Publication number
NO975681D0
NO975681D0 NO975681A NO975681A NO975681D0 NO 975681 D0 NO975681 D0 NO 975681D0 NO 975681 A NO975681 A NO 975681A NO 975681 A NO975681 A NO 975681A NO 975681 D0 NO975681 D0 NO 975681D0
Authority
NO
Norway
Prior art keywords
benzisoxazole
antipsychotic agents
indazole derivatives
indazole
derivatives
Prior art date
Application number
NO975681A
Other languages
English (en)
Other versions
NO975681L (no
Inventor
Mark G Palermo
Lawrence L Martin
Peter A Nemoto
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO975681D0 publication Critical patent/NO975681D0/no
Publication of NO975681L publication Critical patent/NO975681L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO975681A 1995-06-06 1997-12-05 Benzisoxazol- og indazol-derivater som antipsykotiske midler NO975681L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47040095A 1995-06-06 1995-06-06
PCT/US1996/006851 WO1996039397A1 (en) 1995-06-06 1996-05-14 Benzisoxazole and indazole derivatives as antipsychotic agents

Publications (2)

Publication Number Publication Date
NO975681D0 true NO975681D0 (no) 1997-12-05
NO975681L NO975681L (no) 1998-02-05

Family

ID=23867483

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975681A NO975681L (no) 1995-06-06 1997-12-05 Benzisoxazol- og indazol-derivater som antipsykotiske midler

Country Status (20)

Country Link
US (3) US5696113A (no)
EP (1) EP0833820B1 (no)
JP (2) JP3057763B2 (no)
KR (1) KR100304179B1 (no)
AR (1) AR002300A1 (no)
AT (1) ATE199147T1 (no)
AU (1) AU697953B2 (no)
CA (1) CA2218663C (no)
DE (1) DE69611783T2 (no)
DK (1) DK0833820T3 (no)
ES (1) ES2157442T3 (no)
GR (1) GR3035663T3 (no)
HU (1) HUP9802492A3 (no)
IL (1) IL118530A0 (no)
MX (1) MX9709451A (no)
NO (1) NO975681L (no)
NZ (1) NZ307958A (no)
PT (1) PT833820E (no)
WO (2) WO1996039397A1 (no)
ZA (1) ZA964562B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008348A (en) * 1995-06-06 1999-12-28 Hoechst Marion Roussel, Inc. Antipsychotic agents, compositions and method of use
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
UA72189C2 (uk) 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
GB0117531D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
KR100627031B1 (ko) * 2004-09-04 2006-09-21 주식회사 케이티프리텔 등산 정보 서비스 제공 방법 및 장치
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
KR100673033B1 (ko) * 2005-06-21 2007-01-22 (주) 엘지텔레콤 레저 전용 휴대 단말기
CA2637531A1 (en) 2006-02-17 2007-08-30 Memory Pharmaceuticals Corporation Compounds having 5-ht6 receptor affinity
CN102164927A (zh) * 2008-09-23 2011-08-24 弗·哈夫曼-拉罗切有限公司 用作多巴胺d3受体调节剂的异唑并[4,5]吡啶-3-基-哌嗪衍生物
TW201103904A (en) * 2009-06-11 2011-02-01 Hoffmann La Roche Janus kinase inhibitor compounds and methods
CN110117278B (zh) * 2018-02-07 2022-07-19 石家庄以岭药业股份有限公司 烷氧基苯并五元(六元)杂环胺类化合物及其药物用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4853470A (en) * 1983-08-22 1989-08-01 Hoechst-Roussel Pharmaceuticals, Inc. 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
US4670447A (en) * 1983-08-22 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
US4806649A (en) * 1983-08-22 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. 3-(piperidinyl)- and 3- (pyrrolidinyl)-1H-indazoles
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
MX174210B (es) * 1987-02-17 1994-04-28 Pfizer Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos
EP0302423A3 (en) * 1987-08-07 1991-01-09 Hoechst-Roussel Pharmaceuticals Incorporated 1-phenyl-3-(1-piperazinyl)-1h-indazoles, a process and intermediates for their preparation, and the use thereof as medicaments
NZ233525A (en) * 1989-05-15 1991-09-25 Janssen Pharmaceutica Nv Piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers and pharmaceutical compositions
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
US5077405A (en) * 1989-09-11 1991-12-31 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1-Substituted-4-piperazinyl)-1H-indazoles
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
ATE231505T1 (de) * 1991-03-28 2003-02-15 Eisai Co Ltd Neue heterocyclische/cyclische amine
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5206366A (en) * 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds

Also Published As

Publication number Publication date
DK0833820T3 (da) 2001-04-17
GR3035663T3 (en) 2001-06-29
EP0833820B1 (en) 2001-02-14
US5696113A (en) 1997-12-09
WO1996039397A1 (en) 1996-12-12
KR100304179B1 (ko) 2001-11-22
ATE199147T1 (de) 2001-02-15
DE69611783D1 (de) 2001-03-22
JP3122469B2 (ja) 2001-01-09
ZA964562B (en) 1996-12-12
EP0833820A1 (en) 1998-04-08
CA2218663C (en) 2001-07-31
JPH11506728A (ja) 1999-06-15
NZ307958A (en) 1999-02-25
WO1996039405A1 (en) 1996-12-12
IL118530A0 (en) 1996-10-16
AU697953B2 (en) 1998-10-22
DE69611783T2 (de) 2001-09-20
MX9709451A (es) 1998-02-28
HUP9802492A2 (hu) 1999-09-28
AU5746496A (en) 1996-12-24
HUP9802492A3 (en) 1999-10-28
NO975681L (no) 1998-02-05
PT833820E (pt) 2001-07-31
US5965554A (en) 1999-10-12
CA2218663A1 (en) 1996-12-12
ES2157442T3 (es) 2001-08-16
US5852022A (en) 1998-12-22
JP3057763B2 (ja) 2000-07-04
KR19990022264A (ko) 1999-03-25
AR002300A1 (es) 1998-03-11
JPH11507030A (ja) 1999-06-22

Similar Documents

Publication Publication Date Title
DE69611361D1 (de) Chinazolin-derivate
NO974103D0 (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698D1 (de) Chinazolin-derivate
NO307954B1 (no) Orale flytende preparater inneholdende paroxetin-resinat
DK0832061T3 (da) Benzamidderivater og anvendelse deraf som vasopressin-antagonister
KR970707039A (ko) 알루미노-실리케이트 유도체(alumino-silicate derivatives)
DE59608798D1 (de) Endoparasitizide mittel
NO984106D0 (no) Azolobenzazepin-derivater som neurologisk aktive midler
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DK0833820T3 (da) Benzisoxazol- og indazolderivater som antipsykotiske midler
DE69520235D1 (de) Schweisshemmende mittel
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
ATA100695A (de) Prothrombin-derivate
NO975880L (no) Formylderivater anvendt som ikke-ioniske kontrastmidler
DE69628200D1 (de) Diarylalkenylamin-derivate
ATE239018T1 (de) Pyrazol-derivate
ATE204255T1 (de) Carbostyrilderivate als antithrombotische mittel
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
DK0848713T3 (da) Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som antipsykotiske midler
DE59610106D1 (de) Fluorbenzylether-Derivate
DE69624122D1 (de) Aza-anthracyclinone-derivate
ATE202088T1 (de) 4-mercapto-benzoylguanidin-derivate
NO975811D0 (no) Ny anvendelse for pyrrolderivater
DE69515498D1 (de) Naphthyridinderivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application